dots health software glp-1 ATTENTION ALL STATE BENEFIT PLAN PATIENTS‼️ It is important for Points® in the GLP1 Companion

What are compounded medications

These are signs that the glucagon component is driving energy expenditure at a level that meaningfully contributes to the overall weight loss beyond what GLP-1 and GIP provide alone

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors not yet approved by the MHRA or EMA as of April 2025

Plan for Social Meals and Busy Days Eating out, celebrations, or travel can sometimes make routines feel less predictable

mounjaroGLP-1/GIP Support weight loss with the attention-grabbing GLP-1/GIP receptor agonist weight management injection

You can dip into your weeklies at any time